[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO6260133A2 - Derivados de iminopiridina y uso de los mismos - Google Patents

Derivados de iminopiridina y uso de los mismos

Info

Publication number
CO6260133A2
CO6260133A2 CO10146698A CO10146698A CO6260133A2 CO 6260133 A2 CO6260133 A2 CO 6260133A2 CO 10146698 A CO10146698 A CO 10146698A CO 10146698 A CO10146698 A CO 10146698A CO 6260133 A2 CO6260133 A2 CO 6260133A2
Authority
CO
Colombia
Prior art keywords
group
optionally
substituent
imino
carboxamide
Prior art date
Application number
CO10146698A
Other languages
English (en)
Spanish (es)
Inventor
Masato Yoshida
Yasuhisa Kohara
Nabuki Sakauchi
Ayumu Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CO6260133A2 publication Critical patent/CO6260133A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO10146698A 2008-04-23 2010-11-23 Derivados de iminopiridina y uso de los mismos CO6260133A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008113130 2008-04-23

Publications (1)

Publication Number Publication Date
CO6260133A2 true CO6260133A2 (es) 2011-03-22

Family

ID=41216865

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10146698A CO6260133A2 (es) 2008-04-23 2010-11-23 Derivados de iminopiridina y uso de los mismos

Country Status (16)

Country Link
US (1) US20110039892A1 (ja)
EP (1) EP2269989A4 (ja)
JP (1) JPWO2009131135A1 (ja)
KR (1) KR20110005277A (ja)
CN (1) CN102066328A (ja)
AU (1) AU2009238999A1 (ja)
BR (1) BRPI0911464A2 (ja)
CA (1) CA2722031A1 (ja)
CO (1) CO6260133A2 (ja)
CR (1) CR11766A (ja)
DO (1) DOP2010000322A (ja)
EA (1) EA201071228A1 (ja)
EC (1) ECSP10010625A (ja)
IL (1) IL208824A0 (ja)
MX (1) MX2010011651A (ja)
WO (1) WO2009131135A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2535330A3 (en) * 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
AP3749A (en) * 2011-08-26 2016-07-31 Meiji Seika Pharma Co Ltd Method for producing pest controlling agent
AR127663A1 (es) * 2021-11-15 2024-02-14 Pi Industries Ltd Compuestos heteroaromáticos bicíclicos y su uso como agentes de control de plagas

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4840544B1 (ja) 1970-04-24 1973-12-01
DD106377A1 (ja) 1973-06-18 1974-06-12
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
GR78245B (ja) 1980-09-12 1984-09-26 Ciba Geigy Ag
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
DD263759A1 (de) 1986-04-01 1989-01-11 Akad Wissenschaften Ddr Verfahren zur herstellung von 1-substituierten 2-imino-5-(pyrid-4-yl)-1,2-dihydro-pyridin-3-carbonsaeure-derivaten
US5252498A (en) * 1989-08-28 1993-10-12 Semiconductor Energy Laboratory Co., Ltd. Method of forming electronic devices utilizing diamond
DE4021439A1 (de) * 1989-12-14 1991-06-20 Bayer Ag 2-iminopyridin-derivate
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
JP2992677B2 (ja) 1995-06-05 1999-12-20 武田薬品工業株式会社 骨形成促進医薬組成物
ZA991315B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
AU770339B2 (en) 1998-07-17 2004-02-19 H. Lundbeck A/S Compounds specific for the human alpha1d adrenergic receptor and uses thereof
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
CA2426461C (en) * 2000-10-20 2011-04-12 Eisai Co., Ltd. Nitrogen-containing aromatic derivatives
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
US7375100B2 (en) * 2003-06-04 2008-05-20 Pfizer Inc 2-amino-pyridine derivatives useful for the treatment of diseases
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
ES2303758B1 (es) * 2006-02-20 2009-08-13 Laboratorios Almirall S.A. Nuevos derivados de piridin-3-amina.
EP2535330A3 (en) * 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
JP4117008B2 (ja) 2006-10-30 2008-07-09 シャープ株式会社 暗号化装置
CA2693967A1 (en) * 2007-07-19 2009-01-29 Schering Corporation Heterocyclic amide compounds as protein kinase inhibitors
KR20130040258A (ko) * 2008-03-21 2013-04-23 노파르티스 아게 신규한 헤테로시클릭 화합물 및 그의 용도
KR20100130235A (ko) * 2008-04-23 2010-12-10 다케다 야쿠힌 고교 가부시키가이샤 이미노피리딘 유도체 및 이의 용도
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof

Also Published As

Publication number Publication date
MX2010011651A (es) 2010-12-06
US20110039892A1 (en) 2011-02-17
EA201071228A1 (ru) 2011-06-30
BRPI0911464A2 (pt) 2016-07-12
CA2722031A1 (en) 2009-10-29
ECSP10010625A (es) 2011-03-31
IL208824A0 (en) 2011-01-31
CN102066328A (zh) 2011-05-18
EP2269989A1 (en) 2011-01-05
KR20110005277A (ko) 2011-01-17
JPWO2009131135A1 (ja) 2011-08-18
WO2009131135A1 (ja) 2009-10-29
DOP2010000322A (es) 2011-01-31
EP2269989A4 (en) 2011-05-25
AU2009238999A1 (en) 2009-10-29
CR11766A (es) 2010-12-15

Similar Documents

Publication Publication Date Title
AR068764A1 (es) N-piperazin amidas y su uso en medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de faah.
AR066962A1 (es) Compuesto heterociclico fusionado
DOP2006000076A (es) Derivados de ciclopentapiridina y tetrahidroquinolina
SV2010003470A (es) Derivado de oxopirazina y herbicida ref. no. 85061sv (71526)
AR117916A1 (es) Compuesto heterocíclico y su uso
AR068813A1 (es) Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata
CO6231035A2 (es) Novedoso compuesto heteromonociclico que tiene propiedades superiores como agente farmaceutico
AR070558A1 (es) Derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino,proceso para prepararlos, composiciones farmaceuticas que los comprenden y uso de los mismos para el tratamiento de enfermedades dependientes de tirosinquinasas,tales como enfermedades proliferativas.
EA201170093A1 (ru) Замещенные n-оксидпиразиновые производные
CU20130080A7 (es) Derivados bicíclicos sustituidos para el tratamiento del sida
ES2552932T3 (es) Ligandos del receptor nicotínico neuronal de la acetilcolina alfa4beta2
AR077346A1 (es) Compuestos heterociclicos como inhibidores de janus quinasa
UY35361A (es) COMPUESTOS PERFLUORADOS DE 5,6-DIHIDRO-4H-1,3-OXAZIN-2-AMINA COMO INHIBIDORES DE BETA-SECRETASA y MÉTODOS DE USO
PE20130155A1 (es) Derivados de ariletinilo
AR070479A1 (es) Derivado heterociclico fusionado y su uso
AR072016A1 (es) Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato
CO6260133A2 (es) Derivados de iminopiridina y uso de los mismos
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
AR071392A1 (es) Derivados de iminopiridina y su uso
ES2570766T3 (es) Derivados del 1-bencil-3-hidroximetilindazol y su utilización en el tratamiento de enfermedades basadas en la expresión de MCP-1 y CX3CR1
AR070874A1 (es) Compuesto heterociclico fusionado, una composicion farmaceutica que lo comprende y su uso en el tratamiento del cancer.
DOP2010000393A (es) Derivados de dibenzotiazepina y sus usos
CO6290665A2 (es) Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina
AR115020A1 (es) Compuesto heterocíclico nitrogenado y su uso como antagonista del receptor nmda
DOP2006000133A (es) Derivados de 4,5 diarilpiroxol, su preparación y su aplicación en terapeútica